STOCK TITAN

Ecarx Holdings Financials

ECXWW
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

This page shows Ecarx Holdings (ECXWW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ECXWW FY2025

Revenue growth is masking a business where losses shrink through overhead cuts, not through better cash economics.

Between FY2023 and FY2025, revenue rose to $848M while operating margin improved to -6.5%. But gross margin fell to 19.0% and free cash flow remained negative at -$107M, showing that lower overhead—not stronger unit economics—drove most of the accounting improvement, so reported progress has not yet become a self-funding operating model.

FY2025 gross profit was only $161M even after revenue reached $848M, so extra sales did not materially enlarge the gross profit pool. That points to incremental growth arriving at a lower contribution level, which is why the income statement improved only after SG&A and R&D cuts rather than from better merchandise economics.

The balance sheet still carries a funding mismatch: the current ratio was 0.6x and equity remained negative at -$283M, meaning obligations still outweigh the capital base. Cash ended at $87M only because financing supplied $204M, so liquidity improved through external capital rather than from the business paying for itself.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating Ecarx Holdings's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

Ecarx Holdings passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality
1.43x

For every $1 of reported earnings, Ecarx Holdings generates $1.43 in operating cash flow (-$94.4M OCF vs -$66.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-2.3x

Ecarx Holdings earns $-2.3 in operating income for every $1 of interest expense (-$54.8M vs $23.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$847.9M
YoY+9.9%

Ecarx Holdings generated $847.9M in revenue in fiscal year 2025. This represents an increase of 9.9% from the prior year.

EBITDA
-$34.9M
YoY+65.9%

Ecarx Holdings's EBITDA was -$34.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 65.9% from the prior year.

Net Income
-$66.0M
YoY+49.1%

Ecarx Holdings reported -$66.0M in net income in fiscal year 2025. This represents an increase of 49.1% from the prior year.

EPS (Diluted)
$-0.20
YoY+48.7%

Ecarx Holdings earned $-0.20 per diluted share (EPS) in fiscal year 2025. This represents an increase of 48.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$106.6M
YoY-40.4%

Ecarx Holdings generated -$106.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 40.4% from the prior year.

Cash & Debt
$87.1M
YoY+96.9%

Ecarx Holdings held $87.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
19.0%
YoY-1.7pp

Ecarx Holdings's gross margin was 19.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the prior year.

Operating Margin
-6.5%
YoY+9.5pp

Ecarx Holdings's operating margin was -6.5% in fiscal year 2025, reflecting core business profitability. This is up 9.5 percentage points from the prior year.

Net Margin
-7.8%
YoY+9.0pp

Ecarx Holdings's net profit margin was -7.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 9.0 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
$123.3M
YoY-29.5%

Ecarx Holdings invested $123.3M in research and development in fiscal year 2025. This represents a decrease of 29.5% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$12.2M
YoY-23.5%

Ecarx Holdings invested $12.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 23.5% from the prior year.

ECXWW Income Statement

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q4'22
Revenue N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A

ECXWW Balance Sheet

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q4'22
Total Assets $662.4M+33.8% $494.9M-3.8% $514.3M-7.3% $555.0M-7.7% $601.1M-2.5% $616.3M
Current Assets $483.2M+25.2% $385.8M-0.1% $386.1M-4.8% $405.5M-12.5% $463.2M-2.6% $475.7M
Cash & Equivalents $87.1M+1.0% $86.2M+94.8% $44.3M-59.2% $108.4M+35.0% $80.3M-24.9% $106.9M
Inventory $62.3M+78.2% $35.0M+9.8% $31.9M+30.7% $24.4M+7.6% $22.6M+18.7% $19.1M
Accounts Receivable N/A N/A N/A N/A N/A $60.6M
Goodwill $3.7M+2.6% $3.6M+2.5% $3.5M N/A N/A N/A
Total Liabilities $945.9M+19.7% $790.2M+5.1% $752.0M+0.4% $749.0M+4.2% $718.6M+11.9% $642.0M
Current Liabilities $823.0M+12.3% $733.0M+4.9% $698.6M+11.5% $626.4M+5.5% $593.7M+13.8% $521.9M
Long-Term Debt N/A N/A N/A N/A N/A N/A
Total Equity -$282.7M+3.8% -$293.7M-22.5% -$239.7M-20.7% -$198.5M-53.0% -$129.8M-405.1% -$25.7M
Retained Earnings -$1.2B+0.3% -$1.2B-6.1% -$1.1B-12.8% -$996.4M-6.1% -$939.5M-13.5% -$828.0M

ECXWW Cash Flow Statement

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q4'22
Operating Cash Flow N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A

ECXWW Financial Ratios

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q4'22
Gross Margin N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A
Current Ratio 0.59+0.1 0.53-0.0 0.55-0.1 0.65-0.1 0.78-0.1 0.91
Debt-to-Equity -3.35-0.7 -2.69+0.4 -3.14+0.6 -3.77+1.8 -5.54+19.5 -24.99
FCF Margin N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$282.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.59), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Ecarx Holdings (ECXWW) reported $847.9M in total revenue for fiscal year 2025. This represents a 9.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Ecarx Holdings (ECXWW) revenue grew by 9.9% year-over-year, from $771.5M to $847.9M in fiscal year 2025.

No, Ecarx Holdings (ECXWW) reported a net income of -$66.0M in fiscal year 2025, with a net profit margin of -7.8%.

Ecarx Holdings (ECXWW) reported diluted earnings per share of $-0.20 for fiscal year 2025. This represents a 48.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ecarx Holdings (ECXWW) had EBITDA of -$34.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Ecarx Holdings (ECXWW) had a gross margin of 19.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Ecarx Holdings (ECXWW) had an operating margin of -6.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Ecarx Holdings (ECXWW) had a net profit margin of -7.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ecarx Holdings (ECXWW) generated -$106.6M in free cash flow during fiscal year 2025. This represents a -40.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ecarx Holdings (ECXWW) generated -$94.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Ecarx Holdings (ECXWW) had $662.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Ecarx Holdings (ECXWW) invested $12.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Ecarx Holdings (ECXWW) invested $123.3M in research and development during fiscal year 2025.

Ecarx Holdings (ECXWW) had a current ratio of 0.59 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Ecarx Holdings (ECXWW) had a debt-to-equity ratio of -3.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ecarx Holdings (ECXWW) had a return on assets of -10.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Ecarx Holdings (ECXWW) had $87.1M in cash against an annual operating cash burn of $94.4M. This gives an estimated cash runway of approximately 11 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Ecarx Holdings (ECXWW) has negative shareholder equity of -$282.7M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Ecarx Holdings (ECXWW) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ecarx Holdings (ECXWW) has an earnings quality ratio of 1.43x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ecarx Holdings (ECXWW) has an interest coverage ratio of -2.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top